Bio-Rad Releases New Lyphochek® Allergen sIgE Controls to Monitor Precision of In Vitro Allergy Test Procedures

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, announced the release of human-serum based Lyphochek® Allergen sIgE quality controls to monitor precision of in vitro allergy test procedures.

Lyphochek Allergen sIgE Control (Negative and Panel A) are multi-constituent controls that eliminate the need for multiple, single analyte controls. The controls are analyzed for 15 frequently tested allergen-specific immunoglobin E antibodies that include dust mites, mold, dander, foods and grasses. Quantitative insert values are provided for three commonly used, fully automated test systems.

“Bio-Rad is proud to be the largest independent provider of quality controls for in-vitro allergy testing,” said Anna Riviere, Bio-Rad Product Manager, Quality Systems. “Our consolidated controls mean fewer bottles are required and this results in cost savings, increased efficiencies, and less waste.”

When used with Bio-Rad’s Unity™ Interlaboratory Program, the world’s largest comparison peer group and Unity Real Time®, an expert data management software solution designed to improve the effectiveness of quality control processes, allergy testing laboratories are provided with the industry’s most complete solution for daily, optimized quality controls. In addition, Unity Interlaboratory Program participants are able to access their reports online at QCNet™.

Key Benefits

• Lyphochek Allergen sIgE Control (Negative, and Panel A) are multi-constituent controls and are:
• Designed for different instruments and reagent systems that are commonly used in laboratories worldwide
• Offer an excellent three-year shelf life and reconstituted open-vial stability of 28 days when stored between 2°C to 8°C